Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor.
Kahan
B D
BD
Department of Surgery, University of Texas Medical School, Houston.
Kerman
R H
RH
Van Buren
C T
CT
Flechner
S M
SM
Golden
D L
DL
Lewis
R M
RM
D000293:Adolescent; D000328:Adult; D002648:Child; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D066298:In Vitro Techniques; D016030:Kidney Transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage* / Q000627:therapeutic use; D014019:Tissue Donors
D003524:Cyclosporins; D011241:Prednisone